Epratuzumab and 90Y Epratuzumab for B cell non-Hodgkin lymphoma.
依帕珠单抗和钇-90标记的依帕珠单抗,用于B细胞非霍奇金淋巴瘤。
CD72 is a B cell specific receptor that exists in multiple alternative splicing forms.
CD 72是一个重要的B细胞特异性受体,它以多种选择性剪切形式存在。
Take the pancreas to do the immunohistochemistrial staining , and show pancreas islet B cell.
取胰腺做免疫组织化学染色,显示胰岛B细胞。
Instead at the CTL transition stage, B cell deficiency resulted in apoptosis of intra-islet CTL.
细胞缺陷引起胰岛内CTL细胞凋亡但不影响CD8+T淋巴细胞向CTL转化。
A novel method was designed for disease specific B cell epitope mapping and epitope expression in e.
设计了一种新的病原体蛋白质B细胞抗原表位的筛选和重组表达方法。
CD22 expression in B cell NHL tissue and its relationship with clinicopathological characteristics needs further study.
细胞非霍奇金淋巴瘤组织CD 22表达和临床病理特征的关系需进一步研究。
Can you talk about the possibilities of strategies for B cell-directed therapy for the induction of transplant tolerance?
能否请您谈谈抗B细胞疗法诱导移植耐受治疗策略的可能性?
Our results suggest that the loss of CD23 of B cells after activation may serve as a specific marker of B cell activation.
结果表明,B细胞活化后CD 23的表达丧失,可作为B细胞活化的一个特异性标志。
Methods Hybridoma cell line excreting monoclonal antibody against total aflatoxins was produced by using B cell hybridoma technique.
方法利用B细胞杂交瘤技术,建立分泌抗总黄曲霉毒素单克隆抗体杂交瘤细胞株。
Multiple myeloma(MM) is a kind of malignant hyperplastic diseases, which is origined from B cell line and can produce monoclonal immunoglobulin.
多发性骨髓瘤(MM)是一种起源于B细胞系并能够产生单克隆免疫球蛋白的恶性增生性疾病。
Result: The protein from scorpii tegument could increase the transformation of T/B cell distinctly in vitro, while no apparent effect on NK cell.
结果:发现蝎皮的蛋白质组分在体外药理实验中显示对T/B 淋巴细胞转化具有显著促进作用,但对NK活性无明显作用。
The invention also provides methods for detecting IRTA-2, as well as methods for treating various B cell malignancies, including non-Hodgkin's lymphoma.
本发明还提供了检测irta - 2的方法,以及治疗包括非何杰金氏淋巴瘤在内的各种B细胞恶性肿瘤的方法。
The autoactive B cell lineage cells in the bone marrow of BXSB mice are not deleted, which maybe is one of the intrinsic reasons of producing autoantibodies.
并且BXSB小鼠骨髓中的自身反应性B细胞系细胞未被删除,可能是产生自身抗体的内在原因之一。
AIM: To study the expression of predicted B cell epitope peptide in S2 subunit of SARS coronavirus spike protein in E. coli and its mimic antigenicity to S2 protein.
目的:研究预测的SARS冠状病毒刺突蛋白S2亚基B细胞表位肽在大肠杆菌中的表达及其模拟S2蛋白的抗原性。
Histologically, 5 of 9 cases were polymorphoral(peripheral) T cell lymphoma, in the rest 4 of B cell lymphoma, 2 were lymphoplasmacytoid and the other 2 were small cell type.
组织学上多形T细胞淋巴瘤5例,B细胞淋巴瘤4例,其中淋巴浆细胞样型和小细胞性各2例。
Receptor tyrosine kinase-like orphan receptor-1 (ROR1) is expressed on sub-populations of B-cell malignancies and solid tumors, but not by healthy B cells or normal postpartum tissues.
受体酪氨酸激酶样孤儿受体1(ROR1)是在B-细胞恶性肿瘤和实体瘤亚群上表达的,但不在健康B细胞或正常产后组织中表达。
Multiple myeloma is a vicious monoclonal B - cell disease with plasmacyte proliferating slowly.
多发性骨髓瘤是一种浆细胞恶性增生,单克隆免疫球蛋白合成异常的恶性疾病。
The B-cell receptor also represents an important target for patients with B-cell malignancies.
对于B细胞淋巴瘤患者,B细胞受体也代表着一个很重要的药物标靶。
Differential Expression of CD200 in B-Cell Neoplasms by Flow Cytometry Can Assist in Diagnosis, Subclassification, and Bone Marrow Staging.
通过流式细胞仪检测CD 200在B细胞肿瘤中的差异性表达可以协助诊断、分类与骨髓分期。
It is always the non-Hodgkin type, and the vast majority are B-cell lymphomas.
几乎全部都是非霍奇金淋巴瘤,而且绝大部分为B细胞淋巴瘤。
Background: MZL are uncommon B-cell lymphomas. The outcomes and prognostic factors of MZL remain poorly defined.
背景:边缘区淋巴瘤是比较少见的B细胞淋巴瘤。边缘区淋巴瘤的转归和预后因子尚不明确。
B-cell lymphoma was the predominant type, seen in 42 of 45 cases (93.3%).
其中B细胞性淋巴瘤是最常见的病理类型,占93.3%(42/45)。
Objective To discuss further scientific, brief and applied Math Judgment Method about the Function of Pancreas B-cell and Insulin Resistance.
目的进一步探讨胰岛B细胞功能及胰岛素抵抗科学、简便、实用的数学判定法。
Objective to observe the effect and toxicity of rituximab and CHOP regimen (R-CHOP) in the treatment of initially diagnosed diffuse large B-cell lymphoma.
目的观察利妥昔单抗联合CHOP方案(R - CHOP)治疗初治弥漫大B细胞型淋巴瘤的疗效以及毒副反应。
Selection and identification of B-cell epitopes are important for tumor vaccine designing.
因此,筛选并鉴定肿瘤B细胞表位对肿瘤疫苗设计具有重要意义。
Conclusions the treatment effectiveness in newly diagnosed diffuse large-B-cell lymphoma in the elderly has been improved by an individual treatment plan according to evidence-based methods.
结论采用循证医学的方法为初治的老年弥漫性大B细胞淋巴瘤患者制定化疗方案可有效提高治疗效果。
Conclusions: the combination of MabThera and CEOP regimen had high efficacy with mild toxicity in the treatment of aggressive B-cell lymphoma, hopefully may become the standard treatment.
结论:利妥昔单抗联合CEOP方案治疗侵袭性B细胞淋巴瘤疗效高而不良反应轻,有望成为标准治疗。
To analyze CD200 expression by flow cytometry in a large series of B-cell neoplasms in a variety of tissue types in comparison with benign B-lineage cells.
通过流式细胞仪检测,分析在一系列各种组织类型的B细胞肿瘤中CD200表达情况,并与良性B系细胞进行比较。
To analyze CD200 expression by flow cytometry in a large series of B-cell neoplasms in a variety of tissue types in comparison with benign B-lineage cells.
通过流式细胞仪检测,分析在一系列各种组织类型的B细胞肿瘤中CD200表达情况,并与良性B系细胞进行比较。
应用推荐